| Jon A Sexton, MD | |
|
3344 N Futrall Dr, Fayetteville, AR 72703-4057 | |
| (479) 521-8200 | |
| (479) 582-7310 |
| Full Name | Jon A Sexton |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Pulmonary Disease |
| Location | 3344 N Futrall Dr, Fayetteville, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699703496 | NPI | - | NPPES |
| 119310001 | Medicaid | AR | |
| P00189855 | Other | AR | RR MCR |
| 100222050A | Medicaid | OK | |
| 54611 | Other | AR | AR BC/BS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | R-4164 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jon A Sexton, MD Po Box 1523, Fayetteville, AR 72702-1523 Ph: (479) 521-8200 | Jon A Sexton, MD 3344 N Futrall Dr, Fayetteville, AR 72703-4057 Ph: (479) 521-8200 |
News Archive
A new study conducted by researchers from Boston University has found that sarcoidosis accounts for 25 percent of all deaths among women in the Black Women's Health Study who have the disease. The study is the largest epidemiologic study to date to specifically address mortality in black females with sarcoidosis.
The Prostate Conditions Education Council, a national organization committed to men's health and a leader in prostate cancer early detection, released the following statement in response to new clinical practice guideline released today by the American Urological Association.
Ex-prisoners with common psychiatric disorders such as bipolar disorder (manic-depressive disorder) and alcohol and drug abuse are substantially more likely to commit a violent crime after release than other prisoners, according to new research published in The Lancet Psychiatry journal.
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the initiation of Phase II clinical trial of the company's investigative immunomodulatory agent, CYT107 (rhIL-7), in combination with two potent antiretroviral drugs represented by the integrase inhibitor raltegravir (ISENTRESS- Merck & Co.) and the CCR5 inhibitor, maraviroc (SELZENTRY- ViiV Healthcare).
A new study reveals an important and newly discovered pathway used by disease-causing bacteria to evade the host immune system and survive and grow within the very cells meant to destroy them. This discovery may lead to new treatments and vaccines for tuberculosis (TB) and certain other chronic bacterial and parasitic infections.
› Verified 4 days ago
Lauren Cantwell Paulk, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1706 E Joyce Blvd Ste 2, Fayetteville, AR 72703 Phone: 479-966-9370 | |
David R Crittenden, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1408 E Elmwood Dr, Fayetteville, AR 72703 Phone: 479-442-0759 | |
Kim R Agee, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 3344 N Futrall Dr, Fayetteville, AR 72703 Phone: 479-521-8200 Fax: 479-582-7310 | |
Dr. David A Churchill, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3211 N Northhills Blvd, Suite 110, Fayetteville, AR 72703 Phone: 479-571-4338 Fax: 479-571-4015 | |
Dr. Marlan Levan Rhame Iii, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1100 N College Ave, Fayetteville, AR 72703 Phone: 479-443-4301 Fax: 479-587-5929 | |
Waqar M Mehal, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 12 E Appleby, Suite 101, Fayetteville, AR 72703 Phone: 479-463-4444 Fax: 479-463-4499 | |
Dr. Juan I Lombeida, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3232 N North Hills Blvd, Fayetteville, AR 72703 Phone: 479-587-1700 |